ADMA BIOLOGICS INC's ticker is ADMA and the CUSIP is 000899104. A total of 19 filers reported holding ADMA BIOLOGICS INC in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $74,000 | -62.1% | 20,000 | -50.0% | 0.00% | -62.5% |
| Q1 2017 | $195,000 | -61.9% | 40,000 | -60.0% | 0.01% | -68.0% |
| Q4 2016 | $512,000 | -39.6% | 100,000 | -14.5% | 0.02% | -51.9% |
| Q3 2016 | $847,000 | +0.1% | 117,000 | -17.7% | 0.05% | -20.0% |
| Q2 2016 | $846,000 | -27.9% | 142,155 | -2.0% | 0.06% | +27.5% |
| Q1 2016 | $1,173,000 | -9.1% | 145,000 | -9.4% | 0.05% | -42.7% |
| Q4 2015 | $1,291,000 | +0.3% | 160,000 | +3.9% | 0.09% | +56.1% |
| Q3 2015 | $1,287,000 | +54.5% | 154,000 | +71.1% | 0.06% | +72.7% |
| Q2 2015 | $833,000 | +60.2% | 90,000 | +69.5% | 0.03% | +43.5% |
| Q1 2015 | $520,000 | – | 53,100 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital LLC | 3,608,171 | $8,624,000 | 2.44% |
| Broadfin Capital, LLC | 4,226,077 | $10,100,000 | 1.33% |
| MORGENS WATERFALL VINTIADIS & CO INC | 400,000 | $956,000 | 0.85% |
| Consonance Capital Management LP | 4,588,352 | $10,966,000 | 0.81% |
| Perceptive Advisors | 6,521,102 | $14,542,000 | 0.55% |
| Diag Capital Management, LP | 182,100 | $435,000 | 0.50% |
| 683 Capital Management, LLC | 805,000 | $1,924,000 | 0.12% |
| ARDSLEY ADVISORY PARTNERS LP | 50,000 | $120,000 | 0.03% |
| AVANTAX ADVISORY SERVICES, INC. | 65,050 | $156,000 | 0.03% |
| PURA VIDA INVESTMENTS, LLC | 37,170 | $89,000 | 0.02% |